Molecular Templates (MTEM) Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at AACR streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Omega Therapeutics (OMGA) Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance mechanismValidation of novel translational assay enables detection and quantification of site-specific DNA methylation from liquid biopsies to assess target engagement of OTX-2002, our lead clinical-stage epigenomic controller CAMBRIDGE, Mass., April 09, 2024 (GLOBE NEWSWIRE) Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage
Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
On Monday, Vincerx Pharma Inc VINC presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer…